Men could be spared unnecessary treatment for prostate cancer with new detection method

April 6, 2016, St. George's University of London
Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia

Researchers are working to find a way to determine how serious prostate cancer is when first diagnosed to avoid unnecessary treatments, which can cause life long side effects and even death.

Very little is known about how starts and experts from St George's, University of London have developed models which mimic structures found in the prostate to study changes that lead to the progression of prostate cancer.

Dr Ferran Valderrama, of St George's University of London, said:

"The currently available prognostic tests for prostate cancer cannot conclusively tell us whether a tumour will rapidly progress and spread to other tissues or instead will remain confined to the limits of the prostate. As a result, there are a number of men newly diagnosed with prostate cancer that may not receive optimal treatment," he said.

"Improving current procedures for predicting the outcome of a prostate that presents with "suspicious" characteristics of prostate cancer are necessary. If we were able to determine that outcome in a consistent and conclusive manner, it would be easier to define the best approach for treatment for each individual case."

If successful, the experiments in Dr Valderrama's lab would increase the possibilities to intervene at very early times in cases that present features of a more life-threatening tumour.

"We are working towards this strategy and if our experiments continue being successful, we could have in place a new method to more accurately distinguish between high-risk and relatively low-risk disease.", Dr Valderrama said

Researchers in Dr Valderrama's lab have been looking at how cells derived from normal or cancerous prostates organize themselves into structures that look like the ones found in a prostate, known as acini. What they have seen is that, during this process, the more malignant the cells are, the more the acini they form differ from the normal ones and the more they resemble those observed in prostate cancer.

"Based on these cell culture models, we believe a test could be developed to assess how invasive a prostate cell could become when taken from a patient," Dr Valderrama said.

"We believe that this information would help to determine the appropriate treatment for the patient, reducing the burden derived from unnecessary over treatment and overall having a positive outcome in patient survival."

Prostate cancer is the most common cancer in men and across the UK over 44,000 men are diagnosed with prostate cancer every year – that's more than 120 men every day.

Every hour one man dies from prostate cancer – that's more than 10,500 every year.

Explore further: Prostate cancer tied to higher colorectal cancer risk

Related Stories

Prostate cancer tied to higher colorectal cancer risk

March 1, 2016
(HealthDay)—The risk of colorectal cancer is increased after a diagnosis of prostate cancer, according to a study published online Feb. 25 in Cancer.

Active surveillance for prostate cancer can give men good quality of life

March 14, 2016
Choosing ongoing monitoring instead of immediate curative treatment (surgery or radiotherapy) leads to a better overall quality of life for men with low-risk prostate cancer. In fact, the Quality of life (QoL) is about the ...

Research breakthrough could lead to better prostate cancer treatment

November 19, 2015
Cancer researchers from the University of Glasgow and Royal Philips Cancer researchers have identified a gene which could help doctors to predict the aggressiveness of prostate cancer in patients.

Surgery improves survival rates for men with prostate cancer if radiation treatments fail

March 10, 2016
Approximately 14 percent of men will be diagnosed with prostate cancer at some point in their lifetimes, according to the National Institutes of Health. Radiation therapy traditionally has been a primary treatment for the ...

New genetic discovery advances understanding of prostate cancer

October 26, 2015
A new and important genetic discovery, which sheds light on how prostate cancers develop and spread, has been made by an international research team led by scientists at The University of Nottingham.

Targeted antibiotics may help protect against infections in men being tested for prostate cancer

February 1, 2016
A new review indicates that antimicrobial therapy given before clinicians take transrectal ultrasound-guided prostate biopsies to diagnose prostate cancer may lead to lower rates of sepsis, a potentially life-threatening ...

Recommended for you

Scientists create better laboratory tools to study cancer's spread

April 23, 2018
Cancer that has spread, or metastasized, from its original site to other tissues and organs in the body is a leading cause of cancer death. Unfortunately, research focused on metastatic disease has been limited by a lack ...

The role of 'extra' DNA in cancer evolution and therapy resistance

April 23, 2018
Glioblastoma (GBM) is the most common and aggressive form of brain cancer. Response to standard-of-care treatment is poor, with a two-year survival rate of only 15 percent. Research is beginning to provide a better understanding ...

Vitamin A derivative selectively kills liver cancer stem cells

April 23, 2018
Acyclic retinoid, an artificial compound derived from vitamin A, has been found to prevent the recurrence of hepatocellular carcinoma (HCC), the most common form of liver cancer. Now, in research published in Proceedings ...

Size, structure help poziotinib pose threat to deadly exon 20 lung cancer

April 23, 2018
A drug that failed to effectively strike larger targets in lung cancer hits a bulls-eye on the smaller target presented by a previously untreatable form of the disease, researchers at The University of Texas MD Anderson Cancer ...

How to hijack degrading complexes to put cancer cells asleep

April 23, 2018
Newcastle and Dundee University researchers have uncovered an alternative path of how the breast cancer drug palbociclib drives malignant cells into cell death, senescence.

Single-cell study in a childhood brain tumor affirms the importance of context

April 20, 2018
In defining the cellular context of diffuse midline gliomas, researchers find the cells fueling their growth and suggest a potential approach to treating them: forcing their cells to be more mature.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.